Can You Just Come Off Mounjaro — and What Happens When You Do?

The myth worth correcting: that stopping is simply the end of treatment

A question our prescribers hear most weeks is some version of this: "Can I just stop my pen when I reach my goal weight?" The assumption underneath it is that Mounjaro works like a course of antibiotics, finish it, keep the result. That picture is not accurate, and understanding why changes how people plan their exit from treatment.

Tirzepatide works by activating two gut-hormone receptors that regulate appetite and slow how quickly food leaves the stomach. Those effects are entirely tied to the drug being present. Once your last dose clears your system (typically over one to two weeks given tirzepatide's half-life) appetite signalling returns to its previous baseline. For many people that means hunger comes back noticeably, and the portion sizes that felt satisfying on treatment no longer do.

The SURMOUNT-1 trial, published in the New England Journal of Medicine, showed average weight loss of around 20–21% over 72 weeks at the highest dose. A follow-up analysis tracking participants after stopping found substantial regain within 12 months. The weight does not come back overnight, but the trajectory is consistent enough that stopping without a plan is the one thing prescribers most want to avoid.

None of this means you should stay on Mounjaro indefinitely if it is not right for you. It means the question to bring to your prescriber is not just "can I stop" but "what changes before I stop so that stopping goes well," and our guide on how to come off Mounjaro is a good place to start thinking through that.

What actually happens to your body after the last dose

There is no physical withdrawal syndrome with tirzepatide. You will not experience the kind of rebound symptoms associated with stopping certain other medicines. What you are likely to notice instead is appetite returning, sometimes sharply, sometimes gradually over a week or two.

Gastric emptying, which slows on treatment and is part of why smaller meals feel filling, also returns to its usual pace. Some people notice this as a feeling that food passes through more quickly or that they are hungry again sooner after eating. Neither of these is harmful; both are normal physiology reasserting itself.

The practical consequence is that the calorie balance that kept your weight stable on treatment may no longer hold once the drug is gone. If your eating habits have shifted meaningfully during treatment (smaller portions, less frequent snacking, more protein and fibre) those habits become the main thing standing between you and regain. They do not disappear when the drug does, but they need to be firmly established before treatment ends rather than hoped for afterwards.

If you have been considering how to structure a planned stop rather than an abrupt one, coming off tirzepatide in a considered, stepwise way covers the practical steps in more detail. There is also a difference between choosing to stop and needing a short break, which is a separate question.

Short pause versus stopping for good (they are not the same decision

Some people want to come off Mounjaro temporarily) for surgery, for a planned pregnancy, because a dose is temporarily unavailable, or simply to take stock. Others have reached a comfortable weight and want to stop altogether. These call for different conversations with your prescriber.

A short break of a week, for example, is something prescribers consider on a case-by-case basis. The drug's half-life means even a week off is not pharmacologically trivial, and restarting after a gap may mean revisiting an earlier dose to manage tolerability. The specifics of a one-week pause are worth reading through if a temporary stop is what you have in mind.

For a planned permanent stop, the timing matters. Stopping when you are still losing weight is different from stopping once weight has been stable for several months. Most prescribers prefer to see weight stable at a lower level before discussing exit, partly because the habits you have built are more likely to hold when they have already been tested without active dose increases driving further loss.

The NHS patient information for tirzepatide covers the broader context of the medicine. For questions about when the timing of a stop makes clinical sense, the question of when to come off Mounjaro goes into the evidence on stopping timing directly. Cost of ongoing treatment is a real consideration too, the cost context for Mounjaro in the UK sets out what private treatment typically involves.

If you are weighing all of this and want a prescriber's view on your specific situation, you can check your eligibility with our clinical team, every assessment is reviewed personally, the same day.